Accolade, Inc. (ACCD)

Market Cap	727.63M
Revenue (ttm)	388.49M
Net Income (ttm)	-122.73M
Shares Out	77.41M
EPS (ttm)	-1.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	564,266
Open	9.33
Previous Close	9.35
Day's Range	9.13 - 9.47
52-Week Range	6.33 - 17.01
Beta	2.08
Analysts	Strong Buy
Price Target	15.62 (+66.17%)
Earnings Date	Apr 25, 2024

About ACCD

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialis...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jul 2, 2020
• Employees: 2,370
• Stock Exchange: NASDAQ
• Ticker Symbol: ACCD

Financial Performance

In 2022, Accolade's revenue was $363.14 million, an increase of 17.13% compared to the previous year's $310.02 million. Losses were -$459.65 million, 273.3% more than in 2021.

Analyst Forecast

According to 13 analysts, the average rating for ACCD stock is "Strong Buy." The 12-month stock price forecast is $15.62, which is an increase of 66.17% from the latest price.

Price Target

$15.62

(66.17% upside)

Analyst Consensus: Strong Buy